A CITF-funded study published in the Journal of Post-Acute and Long-Term Care Medicine (JAMDA), led by Drs. Dawn Bowdish and Andrew Costa from McMaster University, showed that among residents of long-term care facilities, there was a lower risk of an Omicron infection.
In a preprint, not yet peer-reviewed, CITF-funded researchers found that machine learning and epidemic transmission modelling could accurately predict cases of SARS-CoV-2 infection during the Omicron wave.
A CITF-funded study now published in Open Forum Infectious Diseases by Drs. Marc Romney (University of British Columbia), Zabrina Brumme and Mark Brockman (Simon Fraser University), demonstrated that a third dose of an mRNA vaccine significantly enhanced the magnitude and durability of antibody responses.
A CITF-funded study in preprint, not yet peer-reviewed, by Drs. Marc Romney (University of British Columbia), Zabrina Brumme and Mark Brockman (Simon Fraser University), demonstrated that a third dose of an mRNA vaccine significantly enhanced the magnitude and durability of antibody responses, including among adults over the age of 70, who remained COVID-naïve (those who were not infected with SARS-CoV-2).
Data presented in a CITF-funded study by Drs. Dawn Bowdish and Andrew Costa (both from McMaster University), along with other members of the COVID-in LTC Investigator Group, showed that people aged 65+ who were seropositive with cytomegalovirus (CMV) did not have a higher incidence of COVID-19.
A CITF-funded study in preprint, not yet peer-reviewed, led by Drs. Dawn Bowdish and Andrew Costa from McMaster University, showed that among residents of long-term care facilities, there was a lower risk of an Omicron infection when the person had:
A recent CITF-funded study published in the Canadian Geriatrics Journal concluded that frailty is a critical clinical factor in predicting outcomes of COVID-19 among a group of COVID-19 patients with a median age of 71.
A preprint, not yet peer-reviewed, affirms that infection with cytomegalovirus (CMV), which has been shown to influence immune competence in older adults, does not alter antibody and memory T cell responses to COVID-19 vaccination in older adults living in assisted-living facilities.
This paper, published in Med, characterizes the ability of antibodies acquired via vaccination, infection, or both, to neutralize Omicron.
Research from the CITF-funded PREVENT-COVID study by Drs. Agatha Jassem and Manish Sadarangani from the University of British Columbia confirms the findings of other studies and reinforces the effectiveness of dried blood spot (DBS) tests as a simple and accurate alternative to blood tests.